Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AffaMed Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
AffaMed Therapeutics

AffaMed Therapeutics

Series B

AffaMed Therapeutics: A clinical-stage biopharmaceutical company innovating transformative drugs.

HQ
New York City, NY, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

AffaMed Therapeutics, founded with a mission to develop and commercialize transformative pharmaceutical products, is a clinical-stage biopharmaceutical company. The company focuses on innovative treatments in ophthalmology, neurology, and psychiatry, aiming to address significant unmet medical needs. AffaMed leverages cutting-edge science and strategic partnerships to advance its robust pipeline of therapeutic candidates, targeting both the Chinese market and global healthcare sectors.

AffaMed Therapeutics has garnered attention through collaborations with leading global pharmaceutical companies and notable investors. The company's achievements include advancing several drug candidates into clinical trials and securing strategic partnerships to enhance its research and development capabilities. AffaMed's impact lies in its commitment to bringing groundbreaking therapies to patients, thereby improving health outcomes and setting new standards in the biopharmaceutical industry.

AffaMed Therapeutics - Similar Companies

Affinia Therapeutics logo

Affinia Therapeutics

affiniatx.com

Affigen logo

Affigen

affigen.com

Applied Therapeutics logo

Applied Therapeutics

AimMax Therapeutics logo

AimMax Therapeutics

aimmaxrx.com

Affini-T Therapeutics logo

Affini-T Therapeutics

affinittx.com

Faze Medicines logo

Faze Medicines

fazemed.com

Alphina Therapeutics logo

Alphina Therapeutics

Essential Remedium logo

Essential Remedium

Aria Pharmaceuticals logo

Aria Pharmaceuticals

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Afraxis logo

Afraxis

Theracos logo

Theracos

theracos.com

Visiox logo

Visiox

visioxpharma.com

Therapyx logo

Therapyx

therapyxinc.com

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

AffaMed Therapeutics - Quick Facts

Who are AffaMed Therapeutics' competitors?

Companies similar to AffaMed Therapeutics include Affinia Therapeutics, Affigen, Applied Therapeutics and AimMax Therapeutics.

When was AffaMed Therapeutics founded?

AffaMed Therapeutics was founded in 2019.

Where is AffaMed Therapeutics' headquarters located?

AffaMed Therapeutics' headquarters is located in New York City, NY, US.

When was AffaMed Therapeutics' last funding round?

AffaMed Therapeutics' most recent funding round was for $170M (USD) in March 2021.

How much has AffaMed Therapeutics raised to-date?

As of Mar 30, 2021, AffaMed Therapeutics has raised a total of $170M (USD).

How many employees does AffaMed Therapeutics have?

AffaMed Therapeutics has 175 employees as of Feb 4, 2024.

AffaMed Therapeutics - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified